The effect of levamisole on energy metabolism in Ehrlich ascites tumour cells in vitro.

Abstract

It has been found that levamisole, an anthelmintic drug, used also as an immunomodulator in human cancer therapy, is a strong inhibitor of tumour aerobic glycolysis. In vitro, in Ehrlich ascites tumour (EAT) cells and supernatants it diminishes glucose uptake and lactate formation. It does not, however, exert a similar inhibitory effect on glycolytic… (More)

Topics

Cite this paper

@article{Gumiska1986TheEO, title={The effect of levamisole on energy metabolism in Ehrlich ascites tumour cells in vitro.}, author={Magdalena Gumińska and Teresa Kedryna and E. Marchut}, journal={Biochemical pharmacology}, year={1986}, volume={35 24}, pages={4369-74} }